Stage I Major Salivary Gland Cancer
Low-grade Tumors
High-grade Tumors
Current Clinical Trials
Note: Some citations in the text of this section are followed by a level of
evidence. The PDQ editorial boards use a formal ranking system to help the
reader judge the strength of evidence linked to the reported results of a
therapeutic strategy. (Refer to the PDQ summary on Levels of Evidence for more
information.)
Low-grade stage I tumors of the salivary gland are curable with surgery
alone.[1-3] Radiation therapy may be used for tumors for which resection
involves a significant cosmetic or functional deficit or as an adjuvant to
surgery when positive margins are present.[4] Neutron-beam therapy is
effective in the treatment of poor-prognosis malignant salivary gland
tumors.[5-7]
High-grade stage I salivary gland tumors that are confined to the gland in
which they arise may be cured by surgery alone, though adjuvant radiation
therapy may be used, especially with the presence of positive margins.
Low-grade Tumors
Standard treatment options:
- Surgery alone.
- Postoperative radiation therapy should be considered when the resection margins are positive.
High-grade Tumors
Standard treatment options:
- Localized high-grade salivary gland tumors that are confined to the gland in
which they arise may be cured by radical surgery alone.
- Postoperative radiation therapy may improve local control and increase
survival rates for patients with high-grade tumors, positive surgical
margins, or perineural invasion.[8][Level of evidence: 3iiiDii][9-11]
Treatment options under clinical evaluation:
- Clinical trials exploring newer methods of local control. The role of
chemotherapy remains under evaluation, though data suggest that some salivary
gland tumors may be responsive to chemotherapy.[12,13]
Current Clinical Trials
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage I salivary gland cancer. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI Web site.
References
-
Byers RM, Jesse RH, Guillamondegui OM, et al.: Malignant tumors of the submaxillary gland. Am J Surg 126 (4): 458-63, 1973.
[PUBMED Abstract]
-
Mendenhall WM, Riggs CE Jr, Cassisi NJ: Treatment of head and neck cancers. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds.: Cancer: Principles and Practice of Oncology. 7th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2005, pp 662-732.
-
Woods JE, Chong GC, Beahrs OH: Experience with 1,360 primary parotid tumors. Am J Surg 130 (4): 460-2, 1975.
[PUBMED Abstract]
-
Guillamondegui OM, Byers RM, Luna MA, et al.: Aggressive surgery in treatment for parotid cancer: the role of adjunctive postoperative radiotherapy. Am J Roentgenol Radium Ther Nucl Med 123 (1): 49-54, 1975.
[PUBMED Abstract]
-
Krüll A, Schwarz R, Engenhart R, et al.: European results in neutron therapy of malignant salivary gland tumors. Bull Cancer Radiother 83 (Suppl): 125-9s, 1996.
[PUBMED Abstract]
-
Douglas JG, Lee S, Laramore GE, et al.: Neutron radiotherapy for the treatment of locally advanced major salivary gland tumors. Head Neck 21 (3): 255-63, 1999.
[PUBMED Abstract]
-
Douglas JG, Laramore GE, Austin-Seymour M, et al.: Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy. Int J Radiat Oncol Biol Phys 46 (3): 551-7, 2000.
[PUBMED Abstract]
-
Hosokawa Y, Shirato H, Kagei K, et al.: Role of radiotherapy for mucoepidermoid carcinoma of salivary gland. Oral Oncol 35 (1): 105-11, 1999.
[PUBMED Abstract]
-
Garden AS, el-Naggar AK, Morrison WH, et al.: Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys 37 (1): 79-85, 1997.
[PUBMED Abstract]
-
Mendenhall WM, Morris CG, Amdur RJ, et al.: Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer 103 (12): 2544-50, 2005.
[PUBMED Abstract]
-
Chen AM, Granchi PJ, Garcia J, et al.: Local-regional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 67 (4): 982-7, 2007.
[PUBMED Abstract]
-
Kaplan MJ, Johns ME, Cantrell RW: Chemotherapy for salivary gland cancer. Otolaryngol Head Neck Surg 95 (2): 165-70, 1986.
[PUBMED Abstract]
-
Eisenberger MA: Supporting evidence for an active treatment program for advanced salivary gland carcinomas. Cancer Treat Rep 69 (3): 319-21, 1985.
[PUBMED Abstract]
Back to Top
< Previous Section | Next Section > |